RIA
DFTX

Regal Investment Advisors’s Definium Therapeutics DFTX Stock Holding History

Regal Investment Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Buy
+5,709
New +$141K 0.01% 597
2024
Q1 		– Sell
-14,556
Closed -$53.3K – 595
2023
Q4 		$53.3K Hold
14,556
– – ﹤0.01% 535
2023
Q3 		$45.6K Buy
+14,556
New +$59.8K ﹤0.01% 489

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Regal Investment Advisors's DFTX Position: Q2 2026 in Review

Regal Investment Advisors opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 5,709 shares worth $269K. The stake represents 0.01% of the portfolio and ranks #597 among its holdings. This is a return to the name: Regal Investment Advisors previously reported a position in DFTX as recently as Q4 2023.

Regal Investment Advisors first reported a position in DFTX in Q3 2023 and has held it in 3 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Regal Investment Advisors held 5,709 shares of Definium Therapeutics worth $269K as of Q2 2026.
  • Definium Therapeutics was a new Regal Investment Advisors position in Q2 2026.
  • Definium Therapeutics made up 0.01% of Regal Investment Advisors's portfolio in Q2 2026, its #597 holding.
  • Regal Investment Advisors first reported a position in Definium Therapeutics in Q3 2023 and has held it in 3 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Regal Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.